Literature DB >> 5327616

Treatment of Parkinson's syndrome with L-dopa. A double blind study.

C Fehling.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5327616     DOI: 10.1111/j.1600-0404.1966.tb01188.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


× No keyword cloud information.
  17 in total

Review 1.  Genetically engineered mouse models of Parkinson's disease.

Authors:  Donna M Crabtree; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2011-08-03       Impact factor: 4.077

Review 2.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

3.  Treatment of Parkinson's syndrome with L-DOPA on an out-patient basis.

Authors:  C Fehling
Journal:  Z Neurol       Date:  1972

4.  Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.

Authors:  U K Rinne; V Sonninen; T Sirtola
Journal:  Z Neurol       Date:  1972

5.  [Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes)].

Authors:  W Birkmayer; M Mentasti
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1967-08-08

6.  L-DOPA in Parkinson's Disease.

Authors:  F H McDowell; J E Lee
Journal:  Calif Med       Date:  1970-10

7.  The short-term effect of nicotine chewing gum in patients with Parkinson's disease.

Authors:  P Clemens; J A Baron; D Coffey; A Reeves
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

8.  Dopa and parkinsonism.

Authors: 
Journal:  Br Med J       Date:  1967-06-24

9.  Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa.

Authors:  D B Calne; J L Reid; S D Vakil; S Rao; A Petrie; C A Pallis; J Gawler; P K Thomas; A Hilson
Journal:  Br Med J       Date:  1971-09-25

10.  A controlled study of L-DOPA in Parkinson's disease.

Authors:  W W Hofmann; R L Ryan
Journal:  Calif Med       Date:  1970-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.